Interestingly, although the exact role of CMG2 in tumorigenesis and progression is not well described, the interest in CMG2’s angiogenic properties as targets for anti-tumor therapy are high, resulting in several reports on inhibitors putatively useful for treatment [44,45,46,47,48]. Here, ANTXR2 is linked to neoplasm.